PRESS RELEASE MOJAVE study on track to start in Q2 2023 as planned, with initial data by year-end Randomized, controlled study in US seeking to confirm strong efficacy data seen in RED DESERT and …
Read Full Story at source (may require registration)
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024
- FTSE 100 Modestly Higher In Cautious Trade - November 27, 2024
- CAC 40 Slides As French Risk Premium Peaks - November 27, 2024